All Stories

  1. Chapter 7 – Pathogenesis of otitis media – A review of the literature between 2015 and 2019
  2. The human milk protein-lipid complex HAMLET disrupts glycolysis and induces death in Streptococcus pneumoniae
  3. HAMLET, a Protein Complex from Human Milk, Has Bactericidal Activity and Enhances the Activity of Antibiotics against Pathogenic Streptococci
  4. Growing and Characterizing Biofilms Formed by Streptococcus pneumoniae
  5. A Protein Complex from Human Milk Enhances the Activity of Antibiotics and Drugs againstMycobacterium tuberculosis
  6. BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state
  7. Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection
  8. Streptococcus pneumoniae Modulates Staphylococcus aureus Biofilm Dispersion and the Transition from Colonization to Invasive Disease
  9. Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies
  10. Panel 6: Vaccines
  11. Panel 4: Report of the Microbiology Panel
  12. Low NF-κB Activation and Necroptosis in Alveolar Macrophages: A New Virulence Property of Streptococcus pneumoniae
  13. In Vitro and In Vivo Biofilm Formation by Pathogenic Streptococci
  14. Host Physiologic Changes Induced by Influenza A Virus Lead toStaphylococcus aureusBiofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease
  15. In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector
  16. Directed vaccination against pneumococcal disease
  17. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization
  18. Structure and Potential Cellular Targets of HAMLET-like Anti-Cancer Compounds made from Milk Components
  19. Halothane Modulates the Type I Interferon Response to Influenza and Minimizes the Risk of Secondary Bacterial Pneumonia through Maintenance of Neutrophil Recruitment in an Animal Model
  20. Absence of capsule reveals glycan-mediated binding and recognition of salivary mucin MUC7 byStreptococcus pneumoniae
  21. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease
  22. Protective effects of human milk antimicrobial peptides against bacterial infection
  23. Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation
  24. Pneumococcal Genetic Transformation During Colonization and Biofilm Formation
  25. Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design
  26. Dynamic Changes in the Streptococcus pneumoniae Transcriptome during Transition from Biofilm Formation to Invasive Disease upon Influenza A Virus Infection
  27. Hybrid bio-synthetic gene delivery
  28. Monitoring Changes in Membrane Polarity, Membrane Integrity, and Intracellular Ion Concentrations in Streptococcus pneumoniae Using Fluorescent Dyes
  29. Pneumococcal Adaptive Responses to Changing Host Environments
  30. Small‐angle X‐ray scattering of BAMLET at pH 12: A complex of α‐lactalbumin and oleic acid
  31. Streptococcus pyogenes Biofilm Growth In Vitro and In Vivo and Its Role in Colonization, Virulence, and Genetic Exchange
  32. Biofilm Formation Enhances Fomite Survival of Streptococcus pneumoniae and Streptococcus pyogenes
  33. A Complex of Equine Lysozyme and Oleic Acid with Bactericidal Activity against Streptococcus pneumoniae
  34. Internalization and Trafficking of Nontypeable Haemophilus influenzae in Human Respiratory Epithelial Cells and Roles of IgA1 Proteases for Optimal Invasion and Persistence
  35. Interkingdom Signaling Induces Streptococcus pneumoniae Biofilm Dispersion and Transition from Asymptomatic Colonization to Disease
  36. Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET
  37. High Levels of Genetic Recombination during Nasopharyngeal Carriage and Biofilm Formation in Streptococcus pneumoniae
  38. The Human Milk Protein-Lipid Complex HAMLET Sensitizes Bacterial Pathogens to Traditional Antimicrobial Agents
  39. A Novel Initiation Mechanism of Death in Streptococcus pneumoniae Induced by the Human Milk Protein-Lipid Complex HAMLET and Activated during Physiological Death
  40. Pneumococcal Interactions with Epithelial Cells Are Crucial for Optimal Biofilm Formation and ColonizationIn VitroandIn Vivo
  41. Oleic acid is a key cytotoxic component of HAMLET-like complexes
  42. A novel method for preparation of HAMLET-like protein complexes
  43. Role of Dihydrolipoamide Dehydrogenase in Regulation of Raffinose Transport in Streptococcus pneumoniae
  44. Apoptosis-Like Death in Bacteria Induced by HAMLET, a Human Milk Lipid-Protein Complex
  45. Streptolysin O Inhibits Clathrin-Dependent Internalization of Group A Streptococcus
  46. PerR Confers Phagocytic Killing Resistance and Allows Pharyngeal Colonization by Group A Streptococcus
  47. Enzymatic Characterization of Dihydrolipoamide Dehydrogenase from Streptococcus pneumoniae Harboring Its Own Substrate
  48. Mg2+ signalling defines the group A streptococcal CsrRS (CovRS) regulon
  49. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae
  50. Enhancement of Streptolysin O Activity and Intrinsic Cytotoxic Effects of the Group A Streptococcal Toxin, NAD-Glycohydrolase
  51. Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signalling
  52. Cytolysin-dependent evasion of lysosomal killing
  53. Relative Roles of Genetic Background and Variation in PspA in the Ability of Antibodies to PspA To Protect against Capsular Type 3 and 4 Strains of Streptococcus pneumoniae
  54. Regions of PspA/EF3296 Best Able To Elicit Protection against Streptococcus pneumoniae in a Murine Infection Model
  55. Characterization of the dihydrolipoamide dehydrogenase from Streptococcus pneumoniae and its role in pneumococcal infection
  56. Hamlet — A Complex from Human Milk that Induces Apoptosis in Tumor Cells but Spares Healthy Cells
  57. In Vivo Activation of Dendritic Cells and T Cells during Salmonella enterica Serovar Typhimurium Infection
  58. Characterization of Binding of Human Lactoferrin to Pneumococcal Surface Protein A
  59. Morphological and functionalin vitroandin vivocharacterization of the mouse corpus cavernosum
  60. A folding variant of human α‐lactalbumin induces mitochondrial permeability transition in isolated mitochondria
  61. Conversion of α-lactalbumin to a protein inducing apoptosis
  62. A folding variant of α‐lactalbumin with bactericidal activity against Streptococcus pneumoniae
  63. A folding variant of α‐lactalbumin with bactericidal activity against Streptococcus pneumoniae
  64. Protease Activation in Apoptosis Induced by MAL
  65. Molecular Characterization of  -Lactalbumin Folding Variants That Induce Apoptosis in Tumor Cells
  66. Multimeric α-Lactalbumin from Human Milk Induces Apoptosis through a Direct Effect on Cell Nuclei
  67. Aspects on the Interaction ofStreptococcus pneumoniaeandHaemophilus influenzaewith Human Respiratory Tract Mucosa
  68. Antibodies to pneumococcal polysaccharides in human milk: lack of relationship to colonization and acute otitis media
  69. Apoptosis induced by a human milk protein.